Skip to main content
. 2015 Jan 5;1:50. doi: 10.3389/fsurg.2014.00050

Table 3.

Unadjusted survival analysis stratified by biomarkers identified in immunohistochemistry (IHC).

Biomarker Hazards ratio (95% CI) p-value
COX-2 0.06 (0.005–0.71) 0.02
RRM1 0.26 (0.04–1.57) 0.14
SPARC (Poly) 0.15 (0.02–1.3) 0.08
TS 1.00 1.00

COX-2, cyclooxygenase-2; RRM1, ribonucleotide reductase M1; SPARC, secreted protein acidic cysteine-rich; TS, thymidylate synthase.